An LC-MS MS Method Development and Validation for the Quantification of Infigratinib in K2EDTA Human Plasma. Int. J. Pharm. Sci. Drug Res. 2024, 16 (1), 86-91. https://doi.org/10.25004/IJPSDR.2024.160112.